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P
lastic surgeons have a substantial variation in 
surgical practice for similar diagnoses and con-
ditions. For example, women with breast hy-
pertrophy are offered breast reduction surgery with 
over half a dozen different pedicles and incision types 
depending on the consultant surgeon and patient 
preference. This difference in practice is not limited 
to the health state/diagnosis, borders, race, ethics, or 
health care policy. Indeed, even within the same insti-
tution, patients with the same condition are treated 
differently with respect to medical and surgical prac-
tice. Whose technique is “superior”? Which patient is 
receiving “better care”? Does the lack of uniformity in 
surgical practice indicate that all techniques are equal 
for the care of one condition in different patients? 
Or does it mean that there is not enough evidence 
to prove which procedure is “superior”? Outcomes 
research helps answer such questions by providing 
the relation between clinical care and their end re-
sults.1–3 As Clancy and Eisenberg4 outlined, outcomes 
research help measure the end results of health care.
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Summary: Outcome studies help provide the evidence-based science ratio-
nalizing treatment end results that factor the experience of patients and 
the impact on society. They improve the recognition of the shortcoming in 
clinical practice and provide the foundation for the development of gold 
standard care. With such evidence, health care practitioners can develop ev-
idence-based justification for treatments and offer patients with superior in-
formed consent for their treatment options. Furthermore, health care and 
insurance agencies can recognize improved cost-benefit options in the pur-
pose of disease prevention and alleviation of its impact on the patient and 
society. Health care outcomes are ultimately measured by the treatment of 
disease, the reduction of symptoms, the normalization of laboratory results 
and physical measures, saving a life, and patient satisfaction. In this review, 
we outline the tools available to measure outcomes in plastic surgery and 
subsequently allow the objective measurements of plastic surgical condi-
tions. Six major outcome categories are discussed: (1) functional measures; 
(2) preference-based measures and utility outcome scores; (3) patient sat-
isfaction; (4) health outcomes and time; (5) other tools: patient-reported 
outcome measurement information system, BREAST-Q, and Tracking Op-
erations and Outcomes for Plastic Surgeons; and (6) cost-effectiveness anal-
ysis. We use breast hypertrophy requiring breast reduction as an example 
throughout this review as a representative plastic surgical condition with 
multiple treatments available. (Plast Reconstr Surg Glob Open 2014;2:e189; doi: 
10.1097/GOX.0000000000000104; Published online 29 July 2014.)
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Plastic surgical conditions and health states’ se-
verity are often subjectively graded. For example, the 
amount of breast tissue that requires excision in a 
breast reduction surgery varies not only according 
to the patient’s and surgeon’s subjective desires but 
also according to the breast weight cutoffs that in-
surance agencies and health care policy makers have 
subjectively set. Furthermore, are we able to com-
pare the objective value of living with severe breast 
hypertrophy with other health states within different 
specialties? For example, can we objectively compare 
living with severe breast hypertrophy with living with 
severe renal failure?
Because of the subjective endpoints that catego-
rize most conditions treated by plastic surgeons, 
there can be a false sense of “less urgency” or “less 
importance” to their treatment. Coupled with the 
fact that only a few plastic surgery conditions are life 
threatening, our specialty may be falsely perceived 
with “less priority” by insurance agencies and policy 
makers, thus restricting funding, operative times, 
and insurance coverage in the future.
Outcomes research provides the scientific evi-
dence relating the treatment end results that factor 
the experience of patients and the impact on soci-
ety.5,6 It helps recognize the shortcoming in clinical 
practice and provide rationale for the development 
of gold standard care.5,6 With such evidence, health 
care practitioners can develop evidence-based ra-
tionale for treatments and provide patients with 
informed consent for their treatment options. Fur-
thermore, health care and insurance agencies can 
identify improved cost-benefit options in the pur-
pose of disease prevention and the alleviation of its 
impact on the patient and society.5–7 Our aim in this 
review is to outline the tools available to measure 
outcomes in plastic surgery and subsequently allow 
the objective measurements of plastic surgical con-
ditions. We use breast hypertrophy requiring breast 
reduction as an example throughout this review as 
a representative plastic surgical condition with mul-
tiple treatments available.
TOOLS TO MEASURE OUTCOME 
STUDIES
Health care outcomes are ultimately measured 
by the treatment of disease, the reduction of symp-
toms, the normalization of laboratory results and 
physical measures, saving a life, and patient satisfac-
tion. Many validated tools exist today to objectively 
measure such endpoints and can be subdivided into 
4 categorical endpoints4: (1) Health perception: a 
person’s score of overall health; (2) Functional mea-
sures: an assessment of the gross impact of health 
care on health; (3) Preference-based measures: have 
been developed from business and economy litera-
ture as standardized tools to evaluate the functional 
status. They are designed to place value on particular 
health states; and (4) Patient satisfaction: factors in 
interpersonal aspects, psychological behaviors, and 
technical aspects of care. Many validated outcomes 
measure instruments available in the literature do 
provide more than one type of endpoint objective 
measures. Consequently, it is important to note that 
many of the available tools can fall into more than 
1 of the 4 categories listed. This can be said, for ex-
ample, for patient-reported outcome measurement 
information system (PROMIS) and European qual-
ity of life (EuroQol). We have categorized the widely 
used measures into the most fitting category. Tools 
such as PROMIS however, are validated measures of 
more than one outcomes endpoint. Consequently, 
we have created a fifth categorical outcome tools 
subdivision to include such tools. Moreover, a fifth 
group can include a combination of the above 4 end-
points or large outcome-specific databases. Figure 1 
categorically illustrates the available outcome tools. 
The choice of which outcome measure to use can 
depend on the medical or surgical specialty and the 
specific endpoints in question.
Plastic surgery is a diverse specialty that encom-
passes a variety of subspecialties including cranio-
facial surgery, hand surgery, microsurgery, breast 
reconstruction, burn care, pediatric plastic surgery, 
general reconstruction, and aesthetic surgery. Even 
within each subspecialty, there is a diversity of pro-
cedures that are performed for the treatment of 
the same condition. Alternate interventions can be 
compared and validated using outcome evidence-
based and preference-based measures. These mea-
sures will help replace the traditional evaluation of 
surgical success in terms of subjective aesthetic out-
comes to more objective measures such as sustain-
ability of aesthetic results, preservation of function, 
or pain relief.8
HEALTH PERCEPTION
Health perception is measured by the patient’s 
symptoms. It helps quantify the global health of an 
individual and has been shown to be a good predic-
tor of death and seeking health care.9,10 These tests 
are performed by practitioners inquiring their pa-
tients about validated symptoms using published and 
established standardized questions. For example, in 
the case of breast hypertrophy, The Breast-Related 
Symptoms Questionnaire has been used as a validat-
ed 13-item analysis for the measure of health percep-
tion in patients with severe breast hypertrophy.11 The   Sinno et al. • Utility of Outcome Studies in Plastic Surgery
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average scores are linearly transformed to a scale 
from 0 (greater number, more severe symptoms) to 
100 (fewer and less severe symptoms). These scores 
can be divided by 100 for comparison to other stan-
dardized outcome scores.
FUNCTIONAL MEASURES (SF-36)
Functional measures are used to determine the 
overall influence of health care provided to an indi-
vidual on his/her global health and the impact on 
his/her specific disease. They objectively measure 
the ability of patients to perform relevant activities 
of daily living. These activities can range from self-
care to specific functions of a given anatomical re-
gion. These functional measures can be compared 
to those attained before and after an intervention 
to assess the effect the intervention has had on the 
patient’s functional status.
Generally, functional measures should include 
inquiries on (1) physical function; (2) mental 
function; (3) psychological distress; (4) social in-
teractions; and (5) general health perceptions.12 
The SF-36 is an example of an instrument to at-
tain functional measures that determines health 
status in outcome studies.13 On a multi-item scale, 
it measures 8 health concepts that are related to 
the health problem(s): (1) limitations in physi-
cal activities; (2) limitations in social activities; (3) 
limitations in usual function activities (secondary to 
physical problems); (4) limitations in usual function 
activities (secondary to emotional problems); (5) 
general mental health (psychological distress and 
well-being); (6) bodily pain; (7) vitality (energy and 
fatigue); and (8) general health perception. It is eas-
ily self-administered and simple to use and thus has 
become widely used in clinical practice and trials. 
Other functional measure tools include Veterans 
RAND-36, Veterans RAND-12, and PROMIS global.
PREFERENCE-BASED MEASURES AND 
UTILITY OUTCOME SCORES
Preference-based measures allow the objective 
standardization of health status and well-being. Util-
ity scores are validated preference-based measures 
that can be used in plastic surgery outcome studies. 
Utility assessments are an established and published 
recognized method of determining health state pref-
erences in health economics and medicine.14–18 Util-
ity scores were first introduced to the plastic surgery 
literature by Kerrigan et al.19,20 These measures range 
from 0 (death) to 1 (perfect health). As such, differ-
ent health states can be compared to one another by a 
numeric value. For example, the utility outcome score 
of living with severe breast hypertrophy was found to 
be 0.86.19,20 This utility score can now be compared 
to other health states such as living with kidney trans-
plantation after severe renal failure (0.84).19,21
Fig. 1. Tools used in outcome studies. Five general subdivisions can be used to categorize outcome studies. A definition and 
examples are provided below each subdivision.PRS GO • 2014
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To objectify the burden of a particular health 
state, different tests have been designed to attain 
utility outcome scores.16,17,19,20 Some of the more pop-
ular tools include the standard gamble,22 time trade-
off,17 and visual analogue scale.23 The utilization of 
all 3 tools for obtaining utility scores is optimal to 
minimize the inherent weaknesses of any single test. 
In the standard gamble, subjects are asked to choose 
between 2 choices: to either remain in a given health 
state or take a chance (gamble) with some probabil-
ity of success (perfect health) and some probability 
of failure (death). Percentages of success and failure 
are systematically alternated until the subject is in-
different between taking the gamble and remaining 
in the described health state. The utility score is de-
rived from this point of indifference by the following 
formula: utility health state = (1.00 − risk of death at 
the point of indifference) ÷ 100. A bisecting search 
routine algorithm is used to determine the subject’s 
point of indifference. Typically, 6 iterations are used 
in the algorithm.20,24 If the subject has declined to 
accept a 1% risk of death, the test asks whether he 
or she would accept any chance of death. To avoid 
the biasing effect of phrasing every question in terms 
of the risk of death,25 every statement should be re-
phrased in terms of the probability of living in perfect 
health. “Smiley faces” and Xs should be used as visu-
al aid tools to facilitate the subject’s comprehension 
of percentage of perfect health for the time trade-off 
and life years remaining for the standard gamble.20 
Figure 2 demonstrates an example of utility assess-
ment through a standard gamble survey. In the time 
trade-off, the subject is asked to choose   between liv-
ing a specified number of years in the health state 
(eg, 36 years) or “trading-off” some of those years to 
live in perfect health. The number of years traded 
off in the time trade-off task is systematically alter-
nated using a similar bisecting search routine algo-
rithm until the indifference point of the subject is 
found (Fig. 3). The utility value is derived from this 
indifference point: Utility = (number of years speci-
fied in the described health state − number of years 
traded off at the indifference point) ÷ number of 
years specified in the described health state. In the 
visual analogue scale (Fig. 4), the subject is asked to 
score a value of the given health state on a scale from 
0 (death) to 100 (perfect health). The utility score is 
calculated from each subject’s score using the follow-
ing formula: utility health state = score ÷100.
Should utility scores be extracted from patients liv-
ing with the specific health states, family members of 
patients, or a sample of the general population? There 
has been a great debate to answer this question.20 
Fig. 2. Example of the standard gamble survey for monocular 
blindness. To the left are smiley faces and Xs that are visual 
representatives for percentage chance of life and death, re-
spectively. The case scenarios are provided again for each 
frame.
Fig. 3. Example of the time trade-off survey for monocular 
blindness. To the left are smiley faces and Xs that are visual 
representatives for years of life and death, respectively. The 
case scenarios are provided again for each frame.
Fig. 4. Example of the visual analogue scale for blindness. A 
horizontal bar with a cursor is provided for the volunteers to 
slide from 0 to 100. The case scenarios are provided again for 
each frame.  Sinno et al. • Utility of Outcome Studies in Plastic Surgery
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  Attaining utility scores from patients directly has the 
advantage of objectifying and further understanding 
the physical and psychological impact the disease or 
condition has on the individual. However, studies 
have shown that patients living with health states can 
become accustomed to and habituated to the condi-
tion and thus with time become less burdened with 
the condition. For example, Barker et al26 questioned 
the objectivity of attaining utility scores from patients 
with facial disfigurement. They concluded that some 
patients living with facial disfigurement adjust to their 
condition and integrate their appearance into their 
lives. These individuals become accustomed to their 
appearance and health state to the point that they 
would be willing to undergo significantly less risk to 
change their facial appearance.
How about health states where infants are affect-
ed, such as cleft lip and palate? Who should the out-
come studies be conducted on? In these situations, 
it would be impossible to survey the patients because 
of their age and incomprehension of the tests and 
potential impact of the disease. Some have suggested 
that family members or caregivers may be adequate 
alternatives as they may have a better understanding 
of the condition or disease. However, family mem-
bers can be less willing to take risk or gamble for a 
procedure for their children, for example. This find-
ing introduces a risk for bias in attaining objective 
utility scores. Consequently, the assessment of utility 
scores should be from a neutral sample of the gen-
eral population. Moreover, it is the recommendation 
of the Panel on Cost-Effectiveness in Health and 
Medicine that utility assessments be performed on 
a sample from the general population.18 According 
to these guidelines, we have shown the utility scores 
of living with severe facial disfigurement requiring 
facial transplantation to be 0.6627 and those of cleft 
lip and palate to be 0.84.28
PATIENT SATISFACTION
Patient satisfaction outcome studies attempt to 
objectify the patient’s subjective impression of their 
health state or treatment. They can also measure pa-
tient satisfaction with their (1) health care experi-
ence; (2) outcomes compared to expectations; and 
(3) health care providers. These studies transcend 
the definition of a disease or the technical aspect of 
a procedure. Examples of such measures can be ex-
trapolated from tools such as the health-related qual-
ity of life (HR-QOL) and EuroQol.
HR-QOL refers to physical condition and well-
being that affect the daily lives of individual patients. 
It specifically relates to the health domain of the pa-
tients’ existence by evaluating measures of patients’ 
preferences and values, health perceptions, symp-
toms, and function.29 These factors are converted to 
numeric values typically ranging from 0 (mortality) 
to 1 (perfect health/patient satisfaction).
The EuroQol assessment tool was the result of the 
joint development of the European Quality of life 
group (Fig. 5).30 It was developed as a standardized 
non–disease-specific instrument for describing and 
giving value to HR-QOL.30 This tool was intended to 
complement other forms of quality of life measures. 
It was designed as a self-completion survey with 4 
instrument components: (1) description of the re-
spondent’s own health; (2) rating of own health by 
means of visual analogue scale; (3) valuation of stan-
dard set of health states; and (4) background infor-
mation about respondents. Figure 3 is an example of 
the EuroQol that we have used in studies evaluating 
outcomes in plastic surgery.27,28,31–34
HEALTH OUTCOMES AND TIME
There are quality of life measures that integrate 
both health outcomes and time. These tools allow 
the development of a numeric value by the incor-
poration of quantity and quality of life. Examples of 
Fig. 5. Example of EuroQol survey. Five subdivisions of life 
quality are assessed including (1) mobility, (2) self-care, 
(3) usual activities, (4) pain/discomfort, and (5) anxiety/
depression.PRS GO • 2014
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such tests are quality-adjusted life years (QALY), po-
tential years of life lost, disability-adjusted life years, 
health-adjusted life expectancy, and years of healthy 
life.18 Data from such studies can be extrapolated 
to educate decision makers and consequently influ-
ence allocation of health care resources to improve 
population health. The assumption made with these 
tools is that community preferences can represent 
individual preferences.
OTHER TOOLS: PROMIS AND BREAST-Q
PROMIS is a National Institutes of Health–
funded project and can be found at http://www.
nihpromise.org. It was shown to be a highly reliable 
and precise measure of patient-reported health sta-
tus for physical, mental, and social well-being.35,36 
PROMIS instruments are developed using mixed 
qualitative and quantitative methods engaged to 
complement one another in an iterative process. 
The goal of PROMIS is to provide clinicians and 
researchers access to efficient, valid, and responsive 
self-reported measures of health. This method of 
study includes symptoms, function, and well-being. 
PROMIS measures can be used as endpoints in 
clinical trials of effectiveness of treatment. These 
data can be used to design treatment plans and 
the management of chronic disease. Current avail-
able measures of PROMIS include physical activity, 
experiences of stress, family belonging, subjective 
well-being, and pain. PROMIS fits in this fifth sub-
category “other tools” as it is a modular tool that 
can measure many outcome endpoints including 
functional status and effectiveness of treatment. It 
would not be sufficient to include it in only 1 of the 
4 outcome categories.
Similar to PROMIS but specific to breast surgery, 
the BREAST-Q was developed. It is also a modular 
tool that measures more than one outcomes end-
point including functional subscales and satisfac-
tion subscales and thus better fitting in this fifth 
category of “other tools.” Its primary focus was to 
study of the impact and effectiveness of breast sur-
gery from the patient’s perspective.37 The survey is 
subdivided into 4 modules of breast surgery: (1) 
augmentation; (2) reduction (or mastopexy); (3) 
reconstruction; and (4) mastectomy-only patients. 
Each module is based on 6 outcome measures of 
patient satisfaction and HR-QOL in breast surgery: 
(1) satisfaction with breasts; (2) satisfaction with 
overall outcome; (3) psychosocial well-being; (4) 
sexual well-being; (5) physical well-being; and (6) 
satisfaction with care.
The BREAST-Q quantifies patient satisfaction 
and HR-QOL experienced by women undergoing 
breast surgery. The outcomes of such a survey may 
provide further insight into cost-effectiveness analy-
sis, patient and surgeon education, and surgical ad-
vocacy. It allows the perioperative objective measure 
of patient satisfaction and thus has the potential 
to help surgeons improve and modify their perfor-
mance accordingly.
WHICH OUTCOME TOOLS TO USE IN 
PLASTIC SURGERY?
To determine which outcome measures provide 
the greatest yield, it is first important to establish the 
endpoints in questions. After the endpoints have been 
established, investigators can fall back on the 4 cat-
egorical endpoint outcome tools that have been vali-
dated: (1) health perception, (2) functional measures, 
(3) preference-based measures, and (4) patient satis-
faction. Because each outcome measure has inherent 
bias, it can be advantageous to use at least 3 different 
tools to complement one another. Important exam-
ples of objective measures and endpoints in plastic 
surgery include sustainability of aesthetic results, pres-
ervation of function, pain and/or psychological relief.
OUTCOME RESEARCH FUNDING
Patient-Centered Outcomes Research Institute 
was specifically created to support outcome research. 
Its mission is to provide the science and evidence to 
practitioners and patients to help make informed 
decisions in terms of prevention, treatment, and 
care. Its aims are to assess the value of health care 
options that is determined by patients and their 
caregivers. One of the primary aims of this research 
is to answer what patients are to expect given their 
own personal characteristics, conditions, and pref-
erences. The Patient-Centered Outcomes Research 
Institute is funded by a trust fund authorized by the 
US Congress as part of the Patient Protection and 
Affordable Care Act of 2012.
TRACKING OPERATIONS AND 
OUTCOMES FOR PLASTIC SURGEONS
Tracking Operations and Outcomes for Plastic 
Surgeons (TOPS) is another tool specifically made 
for plastic surgeons. This is a registry instrument 
and not by itself an outcome tool. Data derived from 
TOPS can be used to develop important outcome 
measures specifically for plastic surgeons.
This system was launched in 2002 and can be 
found at https://tops.plasticsurgery.org/. TOPS 
is national electronic database of plastic surgery 
procedures provided free of charge by the Ameri-
can Society of Plastic Surgeons. It is Health Insur-
ance Portability and Accountability Act of 1996   Sinno et al. • Utility of Outcome Studies in Plastic Surgery
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(HIPAA) compliant, secure, and confidential. 
TOPS provides plastic surgeons with a means to 
enter clinical and demographic data into a confi-
dential database. With the support of as many plas-
tic surgeons, a great database of procedures and 
treatments can be collected. This database can 
lead to the development of evidence-based prac-
tice parameters and monitoring of clinical out-
comes and emerging trends. This very important 
database can provide evidence-based monitoring 
of outcomes in our field.
COST-EFFECTIVENESS ANALYSIS
Cost-effectiveness analysis is an important out-
comes tool used to establish priorities for funding 
health care programs.38 The clinical outcomes and 
costs associated with any one intervention must be 
weighed against alternative strategies for treating 
the same patients. Additionally, distribution may be 
driven by political objectives. Using this tool, policy-
makers are able to gain a better understanding of 
how to allocate resources among competing uses. 
Furthermore, the incremental cost per incremen-
tal unit of clinical outcome may be determined.38 
In this way, the incremental cost-effectiveness ratios 
of various treatment modalities can be compared 
and set to funding priorities. The result is an objec-
tive assessment of cost which can optimize the net 
health benefit for a target population from a fixed 
budget.38 Although clinicians are more concerned 
with the effectiveness of a treatment regimen rather 
than the benefit attained from spending resources, 
in time, they will likely take into consideration the 
consequences of such decisions and policies. More-
over, they are obliged to take in active role in aid-
ing those directly responsible for these choices.38 
Plastic surgeons have a responsibility to provide 
high-quality economic evaluations that support the 
cost-effectiveness of the procedures they perform.39 
As a specialty, plastic surgery is at the forefront re-
garding introduction of innovative techniques and 
technologies. A majority of which are not only more 
effective but also more costly, necessitating the need 
for cost evaluation.
Economic evaluation encompasses 4 basic con-
cepts: cost-utility analysis, cost analysis, cost-benefit, 
and cost effectiveness.40 The most appropriate type of 
analysis for most plastic surgery interventions may be 
cost-utility analyses primarily because these methods 
use QALY units that integrate both the quantity and 
quality of life gained by a proposed intervention.41 
Cost analysis alone may not useful because it may not 
account for variations in the efficacy of an interven-
tion and focus only on cost. Thus, it is considered a 
partial economic evaluation. Cost benefit entails con-
verting outcomes into monetary values, which can be 
complicated when attempting to monetize patients’ 
time and burden of disease. Furthermore, as a result 
of equity issues, this type of analysis is considered 
discriminatory against those economically disadvan-
taged.40 Economic evaluations have been performed 
in the field of plastic surgery.42–45 Thoma et al45 com-
pared the costs of endoscopic versus open carpel tun-
nel release reporting an additional $124,311/QALY 
when the endoscopic approach was performed, in-
dicating that this technique should not be adopted. 
When a comparison of costs and health utilities for 
unilateral hand transplantation, unilateral prosthe-
sis, bilateral hand transplantation, and bilateral pros-
theses was performed by Chung et al,42 the authors 
reported that although bilateral hand transplanta-
tion was preferred to prosthesis in terms of quality 
of life, it posed an additional $381,961/QALY. Other 
studies have shown that deep inferior epigastric per-
forator flaps are more cost effective than transverse 
rectus abdominis myocutaneous (TRAM) flaps and 
free TRAMs are more cost effective than unipedicled 
TRAMs.43,44 Since most plastic surgeons have not been 
educated in standard health research methodology, 
collaborating with a health economist may be useful 
to ensure proper cost-utility analysis.39 It is important 
to adopt these analyses not only for sensible allocation 
of resources but also to be considered substantial, reli-
able, and relevant information by government, pro-
fessional organizations, and third-party payers.39
CONCLUSIONS
Outcomes research helps provide evidence for 
superior treatments by demonstrating the relation-
ship between clinical care and their end results. 
This scientific evidence illustrates the treatment end 
results that factor the experience of patients and the 
impact on society. It helps recognize the shortcom-
ing in clinical practice and provide rationale for the 
development of gold standard care, consequently 
influencing cost-effectiveness. Moreover, vital in-
formation can be used for plastic surgery care and 
funding allocation and improve patient informed 
consent while allowing clinicians to conform to 
gold standard care. Furthermore, outcome studies 
can objectify subjective health states and outcomes 
in plastic surgery. These data are integral in provid-
ing metric values for comparison with other health 
states and specialties. Future direction in outcomes 
research in plastic surgery should focus on the 
development of tools directed to answer specific 
endpoints such as the BREAST-Q. PROMIS has a 
great potential to be further developed for specific 
health states within plastic surgery. TOPS is a very 
important resource that all plastic surgeons should PRS GO • 2014
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  support. These cumulative tools should continue 
to be developed so that the field may be universally 
improved and standardization of measures be made 
potentially for patient care. 
Samuel J. Lin, MD
Division of Plastic Surgery
Beth Israel Deaconess Medical Center
Harvard Medical School
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